Novel insight into glucagon receptor action: Lessons from knockout and transgenic mouse models

Diabetes, Obesity and Metabolism

Volumn 13, Issue SUPPL. 1, 2011, Pages 144-150

  Vuguin, P M ^a,b   Charron, M J ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL AT MONTEFIORE   (United States)

Author keywords

Diabetes; Gcgr knockout mouse model; Glucagon; Glucagon signalling; Hypoglycaemia; Islets; Pancreas

Indexed keywords

ADENYLATE KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUCAGON LIKE PEPTIDE 1; GLUCAGON RECEPTOR; GLUCOSE; GLUCOSE TRANSPORTER 2; INSULIN; LIPID; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE;

CELL DIFFERENTIATION; CELL SURVIVAL; DIET RESTRICTION; ENZYME ACTIVATION; EXERCISE; EXPERIMENTAL DIABETES MELLITUS; FETUS DEVELOPMENT; FETUS GROWTH; GENE TARGETING; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN DEFICIENCY; INSULIN RELEASE; KNOCKOUT MOUSE; LIVER CELL; NONHUMAN; OBESITY; PANCREAS ISLET; PANCREAS ISLET BETA CELL; REVIEW; SIGNAL TRANSDUCTION; STOMACH EMPTYING; STREPTOZOCIN DIABETES; TRANSGENIC MOUSE;

EID: 79961176667     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2011.01447.x     Document Type: Review

References (52)

1. Burcelin R, Katz EB, Charron MJ. Molecular and cellular aspects of the glucagon receptor: role in diabetes and metabolism. Diabetes Metab 1996; 22: 373-396.
2. Lefebvre PJ. Glucagon and its family revisited. Diabetes Care 1995; 18: 715-730.
3. Rouille Y, Westermark G, Martin SK, Steiner DF. Proglucagon is processed to glucagon by prohormone convertase PC2 in alpha TC1-6 cells. Proc Natl Acad Sci USA 1994; 8: 3242-3246.
4. Kawamori D, Kurpad AJ, Hu J et al. Insulin signaling in alpha cells modulates glucagon secretion in vivo. Cell Metab 2009; 4: 350-361.
5. Ravier MA, Rutter GA. Glucose or insulin, but not zinc ions, inhibit glucagon secretion from mouse pancreatic alpha-cells. Diabetes 2005; 6: 1789-1797.
6. Zhou H, Zhang T, Harmon JS, Bryan J, Robertson RP. Zinc, not insulin, regulates the rat alpha-cell response to hypoglycemia in vivo. Diabetes 2007; 4: 1107-1112.
7. Hauge-Evans AC, King AJ, Carmignac D et al. Somatostatin secreted by islet delta-cells fulfills multiple roles as a paracrine regulator of islet function. Diabetes 2009; 2: 403-411.
8. Boushey RP, Abadir A, Flamez D et al. Hypoglycemia, defective islet glucagon secretion, but normal islet mass in mice with a disruption of the gastrin gene. Gastroenterology 2003; 4: 1164-1174.
9. Salehi A, Vieira E, Gylfe E. Paradoxical stimulation of glucagon secretion by high glucose concentrations. Diabetes 2006; 8: 2318-2323.
10. Yanaihara C, Matsumoto T, Kadowaki M, Iguchi K, Yanaihara N. Rat pancreas contains the proglucagon(64-69) fragment and arginine stimulates its release. FEBS Lett 1985; 2: 307-310.
11. de Heer J, Rasmussen C, Coy DH, Holst JJ. Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas. Diabetologia 2008; 12: 2263-2270.
12. Hoy M, Olsen HL, Bokvist K et al. Tolbutamide stimulates exocytosis of glucagon by inhibition of a mitochondrial-like ATP-sensitive K+ (KATP) conductance in rat pancreatic A-cells. J Physiol 2000; 527: 109-120.
13. Burcelin R, Li J, Charron MJ. Cloning and sequence analysis of the murine glucagon receptor-encoding gene. Gene 1995; 164: 305-310.
14. Jiang Y, Cypess AM, Muse ED et al. Glucagon receptor activates extracellular signal-regulated protein kinase 1/2 via cAMP-dependent protein kinase. Proc Natl Acad Sci USA 2001; 98: 10102-10107.
15. Berglund ED, Kang L, Lee-Young RS et al. Glucagon and lipid interactions in the regulation of hepatic AMPK signaling and expression of PPARalpha and FGF21 transcripts in vivo. Am J Physiol Endocrinol Metab 2010; 4: E607-E614.
16. Kieffer TJ, Habener JF. The glucagon-like peptides. Endocr Rev 1999; 6: 876-913.
17. Kedees MH, Grigoryan M, Guz Y, Teitelman G. Differential expression of glucagon and glucagon-like peptide 1 receptors in mouse pancreatic alpha and beta cells in two models of alpha cell hyperplasia. Mol Cell Endocrinol 2009; 311: 69-76.
18. Abrahamsen N, Lundgren K, Nishimura E. Regulation of glucagon receptor mRNA in cultured primary rat hepatocytes by glucose and cAMP. J Biol Chem 1995; 26: 15853-15857.
19. Pospisilik JA, Hinke SA, Pederson RA et al. Metabolism of glucagon by dipeptidyl peptidase IV (CD26). Regul Pept 2001; 3: 133-141.
20. Hupe-Sodmann K, McGregor GP, Bridenbaugh R et al. Characterisation of the processing by human neutral endopeptidase 24.11 of GLP-1(7-36) amide and comparison of the substrate specificity of the enzyme for other glucagon-like peptides. Regul Pept 1995; 3: 149-156.
21. Kahn CR. Elliot Proctor Joslin. In: Wilkins L-W, ed. Joslin's Diabetes Mellitus, 14th edn. Williams & Wilkins, MA, USA 2005; 183.
22. Porte D Jr, Seeley RJ, Woods SC, Baskin DG, Figlewicz DP, Schwartz MW. Obesity, diabetes and the central nervous system. Diabetologia 1998; 41: 863-881.
23. Eaton RP. Hypolipemic action of glucagon in experimental endogenous lipemia in the rat. J Lipid Res 1973; 3: 312-318.
24. Longuet C, Sinclair EM, Maida A et al. The glucagon receptor is required for the adaptive metabolic response to fasting. Cell Metab 2008; 5: 359-571.
25. Gelling RW, Du XQ, Dichmann DS et al. Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. PNAS USA 2003; 3: 1438-1443.
26. Vuguin PM, Kedees MH, Cui L et al. Ablation of the glucagon receptor gene increases fetal lethality and produces alterations in islet development and maturation. Endocrinology 2006; 9: 3995-4006.
27. Pictet R, Rutter WJ. Development of the embryonic pancreas. In: Steiner DF, Frenkel N, eds. Handbook of Physiology. Washington, DC: American Physiological Society, 1972; 25-66.
28. Ohtsubo K, Takamatsu S, Minowa MT, Yoshida A, Takeuchi M, Marth JD. Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes. Cell 2005; 7: 1307-1321.
29. Wang H, Maechler P, Ritz-Laser B et al. Pdx1 level defines pancreatic gene expression pattern and cell lineage differentiation. J Biol Chem 2001; 27: 25279-25286.
30. Ahlgren U, Jonsson J, Jonsson L, Simu K, Edlund H. Beta-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. Genes Dev 1998; 12: 1763-1768.
31. Itkin-Ansari P, Demeterco C, Bossie S et al. PDX-1 and cell-cell contact act in synergy to promote delta-cell development in a human pancreatic endocrine precursor cell line. Mol Endocrinol 2000; 6: 814-822.
32. Pictet RL, Rall LB, Phelps P, Rutter WJ. The neural crest and the origin of the insulin-producing and other gastrointestinal hormone producing cells. Science 1976: 4223: 191-192.
33. Pictet RL, Rutter W. Development of the embryonic pancreas. Steiner DF, ed. Handbook of Physiology, Section 7: Endocrinology, vol. 1. Washington, DC: American Physiological Society, 1972; 25-66.
34. Serafimidis I, Rakatzi I, Episkopou V, Gouti M, Gavalas A. Novel effectors of directed and Ngn3-mediated differentiation of mouse embryonic stem cells into endocrine pancreas progenitors. Stem Cells 2008; 1: 3-16.
35. Stein R. Insulin gene transcription: the factors involved in cell-type-specific and glucose-regulated expression in islet β cells are also essential during pancreatic development. In: Jefferson LS, ed. Handbook of Physiology, Section 7. The Endocrine System II. Washington, DC: American Physiology Society, 2001; 25-78.
36. Matsuoka T, Artner I, Henderson E, Means A, Sander M, Stein R. The MafA transcription factor appears to be responsible for tissue-specific expression of insulin. Proc Natl Acad Sci USA 2004; 101: 2930-2933.
37. Matsuoka T, Zhao L, Artner I et al. Members of the large Maf transcription family regulate insulin gene transcription in islet β cells. Mol Cell Biol 2003; 23: 6049-6062.
38. Kataoka K, Han SI, Shioda S, Hirai M, Nishizawa M, Handa H. MAfA is a glucose-regulated and pancreatic beta-cell-specific transcriptional activator for the insulin gene. J Biol Chem 2002; 51: 49903-49910.
39. Guillam MT, Hummler E, Schaerer E et al. Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2. Nat Genet 1997; 17: 327-330.
40. Kedees MH, Guz Y, Vuguin PM et al. Nestin expression in pancreatic endocrine and exocrine cells of mice lacking glucagon signaling. Dev Dyn 2007; 4: 1126-1133.
41. Conarello SL, Jiang G, Mu J et al. Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia. Diabetologia 2007; 1: 142-150.
42. Hayashi Y, Yamamoto M, Mizoguchi H et al. Mice deficient for glucagon gene-derived peptides display normoglycemia and hyperplasia of islet {alpha}-cells but not of intestinal L-cells. Mol Endocrinol 2009; 12: 1990-1999.
43. Naslund E, Bogefors J, Skogar S et al. GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans. Am J Physiol 1999; 3: R910-R916.
44. Nauck MA, Niedereichholz U, Ettler R et al. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. Am J Physiol 1997; 5: E981-E988.
45. Umino Y, Everhart D, Solessio E et al. Hypoglycemia leads to age-related loss of vision. Proc Natl Acad Sci USA 2006; 51: 19541-19545.
46. Lee Y, Wang MY, Du XQ, Charron MJ, Unger RH. Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice. Diabetes 2011; 2: 391-397.
47. Berglund ED, Lee-Young RS, Lustig DG et al. Hepatic energy state is regulated by glucagon receptor signaling in mice. J Clin Invest 2009; 8: 2412-2422.
48. Sinclair EM, Yusta B, Streutker C et al. Glucagon receptor signaling is essential for control of murine hepatocyte survival. Gastroenterology 2008; 6: 2096-2106.
49. Marliss EB, Aoki TT, Unger RH, Soeldner JS, Cahill GF Jr. Glucagon levels and metabolic effects in fasting man. J Clin Invest 1970; 12: 2256-2270.
50. Wasserman DH, Spalding JA, Lacy DB, Colburn CA, Goldstein RE, Cherrington AD. Glucagon is a primary controller of hepatic glycogenolysis and gluconeogenesis during muscular work. Am J Physiol 1989; 1: E108-E117.
51. Gelling RW, Vuguin PM, Du XQ et al. Pancreatic beta-cell overexpression of the glucagon receptor gene results in enhanced beta-cell function and mass. Am J Physiol Endocrinol Metab 2009; 3: E695-E707.
52. Fanelli CG, Porcellati F, Rossetti P, Bolli GB. Glucagon: the effects of its excess and deficiency on insulin action. Nutr Metab Cardiovasc Dis 2006; 16(Suppl. 1): S28-S34.